| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |